Mesencephalic Tractotomy and Anterolateral Cordotomy for Intractable Pain


Acknowledgments

The authors wish to thank Mr. Mike Jensen for his valuable assistance with the medical illustrations of this chapter.

The management of pharmaco-resistant pain of cancerous or noncancerous origin constitutes a rather challenging issue for the modern functional neurosurgeon. Various open or stereotactic neurosurgical procedures, such as cingulotomy, amygdalotomy, thalamotomy, mesencephalic tractotomy, stimulation of the periaqueductal gray area, anterolateral cordotomy, implantation of opioid-infusion devices, and more recently deep and cortical electrical stimulation, have been developed for alleviating chronic, medically intractable pain. The existence of numerous surgical options exactly indicates that none of these procedures properly works for all patients suffering from medically intractable pain. Therefore, the management of each patient should be individualized, and the most suitable surgical method should be chosen.

In this chapter, we present a brief outline of the relevant surgical anatomy, a short summary of the historic evolution of mesencephalic tractotomy and anterolateral cordotomy, and a description of indications and the respective surgical techniques. Finally, we review and analyze the results of these procedures and their role in the modern surgical armamentarium for managing chronic, medically intractable pain.

Mesencephalic Tractotomy

Anatomic Background

It is well known that the mesencephalon is topographically divided into three distinct regions: the tectum, the tegmentum, and the basal portion. The tectum, which is a mixture of gray and white matter, is located dorsally to the central gray matter in a cross-section, occupying the dorsal surface of the midbrain. It includes the superior and the inferior colliculi.

The tegmentum constitutes the main, central part of the mesencephalon, and lies anteriorly to the central gray. It contains all the ascending and descending neuronal tracts, including the brachium conjuctivum (superior cerebellar peduncle), the rubrospinal tract, the medial lemniscus, the trigeminal lemniscus, the spinothalamic and spinotectal tracts, the medial longitudinal fasciculus, the central tegmental tract, the lateral lemniscus, and the dorsal longitudinal fasciculus. The brachium conjuctivum represents a massive bundle of fibers, arising from the deep cerebellar nuclei, decussating at the level of the inferior colliculus in the tegmentum, and terminating at the red nucleus and the ventrolateral thalamic nucleus. The rubrospinal tract lies anteriorly to the brachium conjuctivum, and conveys fibers from the red nucleus to the spinal cord and the inferior olive. The medial lemniscus lies laterally to the brachium conjuctivum, and conveys kinesthesia and discriminative touch from the spinal cord to the thalamus. The fibers of the medial lemniscus are somatotopically organized, with the cervical fibers being more medial, while the sacral fibers are more lateral. The trigeminal lemniscus lies medially to the medial lemniscus. The spinothalamic and spinotectal tracts lie laterally to the medial lemniscus and convey pain and temperature sensation from the contralateral side of the body. The fibers of the spinothalamic and spinotectal tracts are somatotopically organized with cervical fibers being more medial, while the sacral ones are the most laterally located ( Fig. 118.1 ). The medial longitudinal fasciculus lies dorsally to the brachium conjuctivum. The central tegmental tract lies dorsally to the brachium conjuctivum and laterally to the medial longitudinal fasciculus, and conveys fibers from the basal ganglia and the mesencephalic nuclei to the inferior olive. The lateral lemniscus lies dorsally and laterally to the spinothalamic tract, conveying auditory fibers. The dorsal longitudinal fasciculus (the fasciculus of Schutz) is a periaqueductal ascending and descending fiber system arising from the hypothalamus and terminating to the autonomic nuclei of the pons and the medulla, and conveys autonomic fibers.

FIGURE 118.1, Schematic diagram of the midbrain at the level of the superior colliculus, demonstrating the anatomic location and the somatotopic organization of the lateral spinothalamic tract. Note also the anatomic location of the usually elicited responses during electrophysiological stimulation.

The basal portion of the mesencephalon includes the cerebral peduncles and the substantia nigra, a pigmented nuclear mass, which lies between the dorsal surface of the cerebral peduncle and the tegmentum. In addition, several nuclear groups can be found in the mesencephalon at the level of the inferior colliculi. These include the mesencephalic nucleus of the trigeminal nerve, the nucleus of the trochlear nerve, the interpeduncular nucleus, the nucleus parabrachialis pigmentosus, the dorsal tegmental nucleus, the ventral tegmental nucleus, the pedunculopontine and the lateral dorsal tegmental nuclei, the dorsal raphe nucleus, the parabigeminal nucleus, the nucleus pigmentosus (locus ceruleus), and the substantia nigra. The red nucleus, the oculomotor nucleus including the Edinger-Westphal and the Perlia nuclei, the interstitial nucleus of Cajal, the rostral interstitial nucleus of the medial longitudinal fasciculus, the Darkschewitsch nucleus, and the nucleus of the posterior commissure can be found at the level of the superior colliculi ( Fig. 118.2 ).

FIGURE 118.2, (A) Axial T2 weighted image of the midbrain at the level of the superior colliculi demonstrating the major nuclei groups. (B) Axial fractional anisotropy image at the level of the midbrain showing the major ascending and descending tracts. Note the circled area, which represents the ascending spinothalamic tracts. (C) Tractography (diffusion tensor imaging, DTI) depicting the ascending spinothalamic tracts bilaterally.

The central gray of the mesencephalon represents a complex anatomical structure. It surrounds the sylvian aqueduct, and contains several nuclei and a mixture of myelinated and unmyelinated fibers. It is well known that the central gray is implicated in pain conduction. Enkephalin, a neuropeptide associated with pain alleviation, has been identified in large quantities in the central gray. It has been postulated that stimulation of ventro-lateral regions of the central gray produces enkephalins, which subsequently act on serotonergic neurons in the medulla oblongata, which in turn project on afferent axons (concerned with pain) in the dorsal horn of the spinal cord to produce analgesia. Contrariwise, stimulation of the lateral and rostral areas of the central gray facilitates pain conduction. Furthermore, the production of several other neuropeptides by different areas of the central gray, such as neurotensin, substance P, cholecystokinin, serotonin, somatostatin, and dynorphin has been demonstrated in numerous studies. The central gray has also been involved in the vocalization process, the modulation of medullary respiratory centers, the vertical gaze, the presence of aggressive behavior, and the control of reproductive behavior.

Historical Evolution

The first open mesencephalic tractotomy for managing medically intractable pain was performed by Dogliotti in 1938. Although he described his surgical procedure as a surgical section of the “lemniscus lateralis” at the level of the rostral pons, it should be considered certain that the level of the incision was at the lower mesencephalon (inferior colliculi). , His surgical methodology consisted of surgical exposure of the lower part of the midbrain, and introduction of an electric coagulator into the lateral sulcus. His initial series included four patients with medically refractory pain. He reported pain abolishment postoperatively in two of them, while there was significant pain reduction in one patient, and the other patient died immediately after surgery. In all his reported cases, there was some degree of hemihypoalgesia associated with paresthesia postoperatively.

Bailey and his coworkers described their experience from performing an open mesencephalic tractotomy for managing medically intractable pain. They performed their tractotomy by making an incision, approximately 8 mm in length and 4 mm in depth, extending from the lateral sulcus of the midbrain to the posterior edge of the inferior colliculus, on a plane between the superior cerebellar artery and the trochlear nerve. They reported excellent pain control postoperatively, while they observed some transient postoperative drowsiness and aphasia in one of their cases, most probably due to surgical manipulation of the dominant hemisphere of their patient.

Similarly, Drake and McKenzie reported their experience from a series of six patients, undergoing mesencephalic tractotomy for drug-resistant upper extremity or facial pain. In all their cases, the patient was placed in a sitting position, while the incision was made through a small occipital bone flap, placed between the sagittal sinus medially and the transverse sinus inferiorly. The overlying occipital lobe was gently retracted in superior and lateral direction, and the tentorium was incised along the straight sinus. The posterolateral aspect of the midbrain was exposed after opening the arachnoid, overlying the cisterna ambiens. A tractotomy incision was placed by using a cordotomy knife. The incision usually extended from the lateral sulcus to the lower pole of the superior colliculus, and it was 5 mm deep. They reported that all their patients had postoperatively no pain and temperature sensation in the contralateral half of their body. However, all their patients developed progressively quite bothersome dysesthesias after surgery, while one patient developed postoperatively severe, burning, dysesthetic pain. Interestingly, the touch, the vibration, and the position sensations remained unaffected after surgery in all their cases. They observed in five sixths of their cases temporary complete homonymous hemianopsia postoperatively, apparently due to the retraction of the occipital lobe, and/or the sacrifice of the cortical occipital veins. The observed hemianopsia was spontaneously resolved with no further sequelae.

Stereotactic mesencephalotomy for pain management was introduced by Spiegel and Wycis in 1947. , In their first attempts, they combined this procedure with thalamotomy for treating patients with chronic, medically refractory pain of noncancerous origin, which showed no response to any previous surgical procedures, such as retrogasserian rhizotomy, sympathectomy, and cordotomy. , In their initial cases, they aimed not only at the spinothalamic and the quintothalamic tracts, lateral to the sylvian aqueduct, but also at the tegmentum adjacent areas, dorsally to the red nucleus. Pneumoencephalography was routinely employed for their surgical planning. Both patients in their initial report demonstrated satisfactory long-term pain relief. ,

In a later study, they described their modified technique, in which the entry point was through a burr hole, placed on a paramedian plane (7.5 mm lateral to the midline) at the interaural level, and the trajectory was inclining 34 degrees posteriorly, passing through the posterior commissure, which was serving as a reference point. A lesion, approximately 5.5 to 9.5 mm in dorso-ventral diameter, was placed 2 to 3 mm posterior and 0 to 3.5 mm inferior to the posterior commissure, thus destroying the spinothalamic and the reticulothalamic tracts at this level, after applying anodal direct electrical current for 60 seconds. Intraoperative electrical stimulation was usually employed in order to physiologically verify the anatomical target, and thus to minimize the possibility of any procedure-related complications. They reported immediate, complete pain relief in 72.2% (39/54 patients), partial relief in 31%, while 20.3% of their patients demonstrated no response. In the case of proximity of the inserted electrode to the deeply seated oculomotor fibers, ipsilateral ocular movements were observed, while tinnitus could occur due to stimulation of the adjacent lateral geniculate body in cases of a laterally placed electrode. Their indications included atypical or postherpetic facial pain, pain secondary to tabes dorsalis, chronic pain secondary to spinal cord and/or spinal roots trauma, cancer-related pain, thalamic and phantom-limb pain. They reported a 7.4% (4/54 patients) mortality rate, limited to patients with thalamic or cancerous pain. They also reported 14.8% permanent postoperative dysesthesia, while ocular disturbances occurred in 3.7%, and permanent motor deficits in 1.8%.

Torvik reported Leksell’s experience with stereotactic mesencephalic tractotomy (SMT). They performed their procedures under local anesthesia, while the Leksell stereotactic apparatus was used. A small burr hole was placed in the parieto-occipital region, and an electrode was stereotactically inserted by utilizing the sylvian aqueduct and the posterior commissure as reference points. An electrical stimulation study was routinely performed for verifying the anatomical target, and subsequently a spherical lesion was placed via a bipolar coagulation (lesioning temperature 52°C to 60°C), extending from the level of the posterior commissure to the rostral level of the trochlear nucleus, in a rostro-caudal direction. A microscopic examination of the lesioned midbrain area in a postmortem autopsy study in their patients, showed a sharply circumscribed cavity filled with debris and macrophages, surrounded by a thin and sparse gliotic rim, with no evidence of retrograde or anterograde corticospinal fiber degeneration. Interestingly, the ipsilateral medial lemniscus and the spinothalamic tract were completely destroyed; the adjacent reticulothalamic tract was massively damaged, while the superior colliculus and the red nucleus were partially destroyed. Torvic reported in his article that despite the extensive lesioning of the reticulothalamic and the spinothalamic tracts at the midbrain, there was still postoperatively some residual pain sensation. He postulated that tracts other than the reticulothalamic and the spinothalamic might be involved in pain propagation.

Orthner and Roeder reported their surgical technique in stereotactic mesencephalic tractotomy in managing patients with trigeminal, postherpetic, phantom-limb, and Dejerine-Roussy syndrome pain. Their anatomical target was at the level of the posterior commissure, 7.5 mm lateral to the midsagittal plane. They routinely employed an electrode and a radiofrequency generator at 30 mA for 30 seconds for making a lesion. In their report, they emphasized the importance of partially destroying the spinoreticular along with the spinothalamic tract, in order to maximize the pain relief effect.

Mazars et al. reported their experience with a different, and more accurate approach (through a transcortical posterior parietal lobe trajectory) for SMT. The proposal of a more precise anatomical target in their clinical series had equally good pain relief rates as a consequence, along with significantly reduced morbidity. The occurrence of postoperative dysesthesia and anesthesia dolorosa was significantly diminished; on the other hand, the occurrence of oculomotor palsies was increased due to the passage of the lesioning electrode through the quadrigeminal plate.

At approximately the same time Amano et al. reported their technique and their results from treating medically intractable pain of cancerous origin with SMT. They performed their procedures under local anesthesia by utilizing either the Sano’s or the Todd-Wells’ stereotactic frame. The surgical planning was based on pneumoencephalography and the Schaltenbrand-Bailey stereotactic atlas. The dorsal portion of mesencephalic tegmentum near the central gray, at the level of the rostral end of the superior colliculus, was used as their anatomical target. The stereotactic coordinates for their selected target was P 14, H –5 to –8, and L 5 to 8, while the laterality of the target was measured from the midline of the sylvian aqueduct. They emphasized that the usage of a frontal entry point could minimize the incidence of postoperative Parinaud syndrome. A radiofrequency lesion was made after electrophysiological confirmation of the target. They reported significant information regarding the electrophysiological profile of the mesencephalic reticular formation, by routinely employing detailed microelectrode recordings.

Nashold and his coworkers employed a slightly different surgical technique for performing SMT. The surgical planning was based on a contrast ventriculography for visualizing the sylvian aqueduct, and the anterior commissure (AC) and posterior commissure (PC). The procedure was routinely performed under local anesthesia. A burr hole was placed 1 cm anterior to the coronal suture, and 1.5 cm from the midsagittal plane. Nashold et al. had developed a mesencephalon stereotactic atlas, which could be used for this anterior approach. After accurate recognition of the rostral end of the sylvian aqueduct and the AC-PC line, an electrode was inserted in a trajectory crossing the AC-PC line at a 65- to 70-degree angle. The latero-medial angulation of the electrode was 2 to 4 degrees off the midsagittal plane. Electrical stimulation could be performed for verifying the anatomical target, and for identifying the fine somatotopic organization of the spinothalamic and the reticulothalamic tracts. A radiofrequency generator was used for 30 seconds for placing a spherical lesion. Nashold et al. initially in their series utilized a target located at the level of the PC, 3 mm posterior to this (“superior colliculus target”), while later on they utilized a target located 5 mm posterior, inferior, and lateral to the PC (“inferior colliculus target”). In their reports they greatly emphasized the importance of intraoperative stimulation for verifying the anatomical target in order to maximize their physiologic effect.

Current Indications for Stereotactic Mesencephalic Tractotomy

The recent advances in neuropharmacology, the development of multidisciplinary pain management strategies, and the emerging of novel neuromodulative surgical techniques have limited the role of SMT, making it a valid treatment option only for those patients with medically refractory pain due to extensive carcinoma involving the head, neck, and/or arm, with likely survival time in the order of 6 (±3) months. Several previous reports have confirmed the achievement of pain relief, and the diminishing of pain-associated anxiety after performing SMT and lesioning of the spinoreticular along with the spinothalamic tracts, in cases of extensive head and neck cancer. , Moreover, the performance of SMT carries the advantage of reducing the patient’s emotional reaction to pain. It has been reported that the postoperative calming effect of the patient’s fear and anxiety after an SMT closely resembles that of a bilateral cingulotomy.

In cases of unilateral facial, neck, and/or arm medically intractable pain of cancerous origin, an SMT on the opposite side should be performed. In cases of bilateral pain, the side of the greatest involvement should be managed. However, it has to be mentioned that Whisler and Voris reported no serious postoperative side effects from placing bilateral SMT lesions in patients with bilateral pain. ,

Patients suffering from phantom-limb pain following avulsion of the brachial plexus, post-cordotomy dysesthesia, or central pain secondary to thalamic syndrome, who failed medical or other surgical treatment, may be candidates for SMT. Although the analgesic effect of SMT wears off in the vast majority of the reported cases, there are a few reports of long-lasting pain relief.

Relative contraindications for SMT are patient’s advanced age (≥70 years), poor general medical condition, short life expectancy, and pre-existing altered level of consciousness.

Surgical Technique

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here